ULBIULBIIndustrials · Electrical Equipment & Parts

ULBI Stock Forecast: Ultralife Corp. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$6.05
−1.94% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 73 of 100 as at 14 Oct 2026 — in the upper half.

Market cap
$102.8M
Ticker Nerd rank
73 / 100
Median analyst target
—
Analysts covering
1
Revenue$47.9M−1.3% y/y
Operating income$3.4M
Net income$2.5M
Free cash flow$735K
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−4.9%
1M
+8.8%
YTD
+5.8%
1Y
−16.1%
From 52W high
−23.9%
From 52W low
+19.8%
$5.05
$7.95
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ULBI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Ultralife Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
73 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
91
Issuance
86
Value
78
Accruals
74
Size
74
Quality
58
Momentum
56
Growth
35
Revisions
25

Volatility (91): The share price has been relatively steady.

Revisions (25): Analysts have, on balance, been cutting their forecasts.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ULBI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ULBI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4.50$5.00$5.50$6.00$6.50$7.00$7.50$8.00Jan 26Apr 26Jul 26Oct 26ULBI

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Recent analyst actionsNewest first
DateFirmActionRatingTarget
15 Nov 2024BenchmarkReiteratesBuy$14
27 June 2024BenchmarkMaintainsBuy—
5 Mar 2024BenchmarkMaintainsBuy—
8 Aug 2023BenchmarkReiteratesBuy—
26 Mar 2021BenchmarkInitiatesBuy—
2 May 2013Ardour CapitalDowngradeReduce—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ULBI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ULBI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, Ultralife Corp. returned −16.1% against +17.5% for the S&P 500, dividends included.

ULBI vs S&P 500, last 12 monthsTotal return, rebased to 100
708090100110120Jan 26Apr 26Jul 26Oct 26ULBIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ULBI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Ultralife Corp. (ULBI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
65.5×

Cheaper than 11% of US stocks

Price / sales
0.5×

Cheaper than 80% of US stocks

Price / book
0.8×

Cheaper than 77% of US stocks

EV / EBITDA
11.3×

Cheaper than 32% of US stocks

Growth & margins
Revenue growth (YoY)
−1.3%

Higher than 25% of US stocks

Earnings growth (YoY)
189.3%

Higher than 90% of US stocks

Gross margin
28.9%

Higher than 32% of US stocks

Operating margin
9.0%

Higher than 62% of US stocks

Net margin
−3.5%

Higher than 25% of US stocks

Returns & dividend
Return on equity
−4.9%

Higher than 40% of US stocks

Return on assets
2.1%

Higher than 59% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Ultralife Corp. (ULBI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Ultralife Corp. has a market value of $102.8M and an enterprise value of $144.1M.

  • Revenue in the twelve months to 30 June 2026: $187.2M. The latest quarter shrank 1.3% year on year.

  • Net income over the same four quarters: −$6.7M, a −3.6% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.40.

  • Free cash flow in the twelve months to 30 June 2026: $2.0M.

  • Shares outstanding: 16.7M.

  • Trailing P/E: 65.5×; forward P/E: 6.9× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Ultralife Corp. employs 678 people — $276K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Oct 2026

Data provided by Twelve Data

Peers

ULBI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelElectrical Equipment & Parts
CompanyMarket capTKN rank
ULBIUltralife Corp.$102.8M
73
OESXOrion Energy Systems, Inc.$98.9M
99
CBATCBAK Energy Technology Ltd.$108.1M
70
NEOVNeoVolta, Inc.$128.5M
10
RFILRF Industries Ltd.$78.6M
75
SKYXSKYX Platforms Corp.$136.8M
44
TGENTecogen, Inc.$68.8M
16

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Ultralife Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ULBI news & analysis

Ultralife Upgraded to Neutral on Backlog & Product Commercialization

Zacks Investment Research · 25 Sept 2026positive

Zacks Investment Research upgraded Ultralife Corp. (ULBI) to a Neutral rating, citing a record backlog, product commercialization, manufacturing improvements, and broader opportunities from vertical integration.

Why it matters — ULBI watchers would care because the upgrade points to strengthening operational fundamentals such as backlog growth and commercialization progress.

Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip

Zacks Investment Research · 12 Aug 2026positive

Ultralife reported improved earnings for the second quarter of 2026 despite a year-over-year decline in revenue, citing stronger margins, a record backlog, and operational gains.

Why it matters — A ULBI watcher would care because the company demonstrated profitability improvement even amid softer revenue, supported by its record backlog and operational efficiency.

Ultralife Q2 Earnings Call Highlights

MarketBeat · 7 Aug 2026positive

Ultralife reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million, and diluted EPS of $0.15, citing stronger gross margins and a record backlog.

Why it matters — The results highlight improved profitability and strong demand, with a record backlog and continued investment in product development across both its battery and communications segments.

Ultralife Corporation (ULBI) Q2 2026 Earnings Call Transcript

Seeking Alpha · 7 Aug 2026neutral

Ultralife Corporation held its Q2 2026 earnings call, and the full transcript of that call has been published by Seeking Alpha. The item provides the transcript covering the company's second-quarter results and management commentary.

Why it matters — ULBI watchers would value access to the full Q2 2026 earnings call transcript for direct insight into the company's quarterly performance and outlook as reported by management.

Ultralife Corporation Reports Second Quarter Results

GlobeNewsWire · 7 Aug 2026positive

Ultralife Corporation reported second quarter 2026 results with sales of $47.9 million, down from $48.6 million a year earlier. Gross margin improved to 28.9% of revenue (26.6% excluding a $1.1 million net IEEPA refund), while operating income rose to $3.4 million, GAAP EPS increased to $0.15, adjusted EBITDA reached $6.1 million, and backlog stood at $117.5 million.

Why it matters — The results show improved gross margin, earnings, and profitability metrics versus the year-ago quarter despite slightly lower sales, along with a modest rise in backlog.

FAQ

Frequently asked questions about ULBI stock

Is ULBI stock a buy right now?

Of the 1 analysts covering Ultralife Corp., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Ultralife Corp. 73 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ULBI?

As at 14 Oct 2026, Ultralife Corp. ranks 73 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (91 of 100).

What is the ULBI stock forecast for 2030?

No analyst covering Ultralife Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ULBI are extrapolating price history, which says nothing about the business.

How has ULBI stock performed over the past year?

Ultralife Corp. returned -16.1% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Ultralife Corp. do?

Ultralife Corporation is a specialized industrial company focused on power solutions and communications systems. Ultralife Corporation designs, manufactures, installs, and maintains batteries, charging systems, uninterruptible power supplies, and custom-engineered energy products through its Battery & Energy Products segment.

What is the latest news on ULBI?

The most recent item we track (Zacks Investment Research, 25 Sept 2026): "Ultralife Upgraded to Neutral on Backlog & Product Commercialization". Zacks Investment Research upgraded Ultralife Corp. (ULBI) to a Neutral rating, citing a record backlog, product commercialization, manufacturing improvements, and broader opportunities from vertical integration.

Company

About Ultralife Corp.

Ultralife Corporation is a specialized industrial company focused on power solutions and communications systems. Ultralife Corporation designs, manufactures, installs, and maintains batteries, charging systems, uninterruptible power supplies, and custom-engineered energy products through its Battery & Energy Products segment. Its Communications Systems segment provides radio frequency amplifiers, power supplies, cable and connector assemblies, integrated communication systems, and related electronics used in mission-critical applications. The company serves government and defense customers alongside commercial markets, including medical, safety and security, energy, industrial, automotive, and consumer electronics sectors. With operations spanning North America, Europe, and Asia, Ultralife Corporation plays a role in supplying reliable power and communications technologies for demanding environments where durability and performance are essential.

CEO Mr. Michael E. Manna · 678 employees · United States · https://www.ultralifecorporation.com